The influence of ofloxacin and pefloxacin on human myelopoiesis in vitro was investigated. Drug concentrations varied from 0.5 to 50 ,ug/ml, and the effect on granulomonocyte precursors was evaluated on cell cultures in agar. Our results indicate that ofloxacin and pefloxacin do not induce inhibition of myelopoiesis.
The new quinolones are antimicrobial agents with a large antibacterial spectrum and a wide distribution in body fluids and tissues. However, some aspects of their toxicity, which appears to be low, need to be defined.
The primary target of all the fluoroquinolones is a bacterial DNA gyrase (topoisomerase II), an essential bacterial enzyme for DNA replication and certain aspects of transcription, DNA repair, recombination, and transposition (17, 18) .
Although the fluoroquinolones are specific for procaryotic enzymes, they also appear to be capable of inhibiting eucaryotic DNA polymerases alpha and beta and deoxynucleotidyltransferase in vitro and in cell-free systems (16) . Moreover, inhibition of DNA polymerase alpha and topoisomerases I and II of mammalian cells was recently observed at high fluoroquinolone concentrations (10) .
In the present work, the interference of fluoroquinolones on the proliferation of eucaryotic cells was evaluated by examining the influence of ofloxacin and pefloxacin on human myelopoiesis in vitro.
The semisolid agar culture system was similar to that described by Pike and Robinson (12) .
Samples of normal human bone marrow were obtained by median sternotomy from patients who were undergoing diagnostic procedures; the bone marrow specimens were eventually considered hematologically normal. Samples of 1 ml were collected in 2 ml of Iscove modified Dulbecco medium and centrifuged through a Ficoll-Hypaque gradient. The mononuclear cells were removed, washed three times, and suspended in Iscove modified Dulbecco medium supplemented with 10% heat-inactivated fetal calf serum and 10% giant cell tumor conditioned medium.
For semisolid medium, warm agar was added to a final concentration of 0.3%. Samples of 1 ml of culture suspension at a final concentration of 2 x 10 cells per ml were dispensed into a 35-by 10-mm petri dish. Cultures were allowed to gel at room temperature and then incubated for 14 days in a humidified atmosphere of 5% C02-95% air at 37°C.
To evaluate the influence of ofloxacin and pefloxacin on myelopoiesis, fresh stock solutions of preservative-free drugs were added at concentrations of 0.5, 5, 10, and 50 ,ug/ ml to the cell suspension before stratification. The experiments were performed in triplicate, and the number of colonies each time was compared with the number of colonies in cultures incubated without drugs.
Each plate was examined after 14 days, and colonies containing more than 40 cells were counted with an inverted * Corresponding author. microscope. Statistical analysis was performed with Student's t test.
The influence of various concentrations of ofloxacin and pefloxacin on the proliferation of human myeloid precursors, expressed as the average number of colonies formed in six bone marrow cultures, is shown in Table 1 . No differences in morphology or size of colonies were observed in the presence of quinolones.
Published data on the relationship between host defense mechanisms and the fluoroquinolones are not always in accordance.
In previous studies with human granulocytes exposed to high concentrations of quinolones, no direct effect was observed on granulocyte chemotaxis, phagocytosis, bacterial killing (5), or oxidative metabolism (3). In human lymphocyte cultures the production of immunoglobulins appeared to be inhibited (7) or not influenced at all (3) . In an animal model, however, the humoral immune response was significantly increased (15) . In two studies quinolones at high concentrations impaired interleukin-1 production by human monocytes (13, 14) , but no effect was observed by other investigators on gamma interferon production by human lymphocytes at pharmacological concentrations (1) . At clinically achievable concentrations, inhibition (1, 9), no effect (8, 11) , and increase (4, 6, 7) of [3H]thymidine incorporation in human mononuclear cells stimulated with different mitogens (phytohemagglutinin, concanavalin A, etc.) have been reported.
Our study also suggests that ofloxacin and pefloxacin do not induce inhibition of myelopoiesis in vitro at suprapharmacological concentrations (50 ,ug/ml).
In other studies on murine myelopoiesis in vitro, no effects of the new quinolone derivatives were observed at clinically achievable concentrations, but inhibition was found at concentrations of 100 ,ug/ml or higher ( increased uptake of radiolabeled thymidine through salvage pathways.
The discordance of the results on the effect of quinolones on the immune system indicates the need for further studies, considering also the intracellular diffusion (2) and storage of these drugs.
